CVNov 18, 2025

SLAM-AGS: Slide-Label Aware Multi-Task Pretraining Using Adaptive Gradient Surgery in Computational Cytology

arXiv:2511.14639v1Has Code
Originality Incremental advance
AI Analysis

This addresses challenges in computational cytology for medical diagnosis, but it is incremental as it builds on existing multitask and gradient surgery methods.

The paper tackled unreliable and costly instance-level labels and low witness rates in computational cytology by proposing SLAM-AGS, a multitask pretraining framework that improved bag-level F1-Score and positive cell retrieval, with the largest gains at low witness rates down to 0.5%.

Computational cytology faces two major challenges: i) instance-level labels are unreliable and prohibitively costly to obtain, ii) witness rates are extremely low. We propose SLAM-AGS, a Slide-Label-Aware Multitask pretraining framework that jointly optimizes (i) a weakly supervised similarity objective on slide-negative patches and (ii) a self-supervised contrastive objective on slide-positive patches, yielding stronger performance on downstream tasks. To stabilize learning, we apply Adaptive Gradient Surgery to tackle conflicting task gradients and prevent model collapse. We integrate the pretrained encoder into an attention-based Multiple Instance Learning aggregator for bag-level prediction and attention-guided retrieval of the most abnormal instances in a bag. On a publicly available bone-marrow cytology dataset, with simulated witness rates from 10% down to 0.5%, SLAM-AGS improves bag-level F1-Score and Top 400 positive cell retrieval over other pretraining methods, with the largest gains at low witness rates, showing that resolving gradient interference enables stable pretraining and better performance on downstream tasks. To facilitate reproducibility, we share our complete implementation and evaluation framework as open source: https://github.com/Ace95/SLAM-AGS.

Foundations

The foundational work for this paper's niche, ranked by how specifically the neighbourhood builds on it — not by global fame.

Your Notes